Delivery Order SPE2DR25D1205-SPE2DR26F1AD9
Award Date 1/20/26
Potential Completion Date 2/10/26
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $6,055.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Zoladex 10.8 mg implant syringes, with an ultimate completion date of February 3, 2026. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. The company...
- The Defense Logistics Agency awarded a $20,186 delivery order to AmerisourceBergen Drug Corp for Zoladex 10.8 mg implant syringes, with an ultimate completion date of February 6, 2026. This firm fixed-price, non-set-aside contract represents a task order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2026. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $11,757.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zoladex 10.8 mg implant syringes, with an ultimate completion date of November 10, 2025. This non-set-aside contract was competitively awarded on October 20, 2025, with performance to be conducted at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $4,334.59 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes. This non-set-aside, firm fixed-price delivery order was competitively awarded on December 11, 2025, with an ultimate completion date of January 5, 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Zoladex 10.8 mg implant syringes with a ceiling value of $23,515.44. This firm fixed-price delivery order, set to be completed by January 14, 2026, will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made on a non-set-aside, competitive basis, reflecting AmerisourceBergen's capability to meet federal procurement standards through...
- The Defense Logistics Agency awarded a $2,155.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zoladex 3.6 mg implant syringes, with an ultimate completion date of February 4, 2026. This competitively awarded contract carries no set-aside designation and represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.999 billion through December...
- The Defense Logistics Agency awarded a $6,055.80 delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Zoladex 10.8 mg implant syringes, with final delivery required by January 29, 2026. This contract utilizes a firm fixed-price structure with no set-aside designation, reflecting a competitive award to the prime contractor. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Zoladex 10.8 mg implant syringes under a firm fixed-price contract with a ceiling value of $7,564.32. The contract is scheduled for ultimate completion by August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Zoladex 10.8 mg implant syringes with a ceiling value of $5,878.86. This firm fixed price delivery order, with an ultimate completion date of December 31, 2025, represents a non-competitive set-aside transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The contract is...
- The Defense Logistics Agency awarded a delivery order valued at $2,789.25 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of October 9, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside award, indicating the procurement was open to all qualified vendors. This delivery order is...